Caricamento...
Clinical efficacy, safety and tolerability of aliskiren monotherapy: a protocol for an umbrella review
INTRODUCTION: Aliskiren is a newly developed medicine. As one of the effective renin–angiotensin–aldosterone system inhibitors, its role in lowering blood pressure has been recognised. However, its safety and tolerability still remain controversial. The aim of the paper is to systematically summaris...
Salvato in:
| Pubblicato in: | BMJ Open |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Publishing Group
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7045264/ https://ncbi.nlm.nih.gov/pubmed/31969367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-033448 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|